Company Filing History:
Years Active: 2016
Title: Sylvain Hanein: Innovator in Genetic Diagnosis
Introduction
Sylvain Hanein is a notable inventor based in Paris, France. He has made significant contributions to the field of genetic diagnosis, particularly in relation to hereditary spastic paraplegias (HSP). His work has implications for understanding and diagnosing this condition, which affects mobility and quality of life.
Latest Patents
Hanein holds a patent for the "Diagnosis of hereditary spastic paraplegias (HSP) by identification of a mutation in the ZFYVE26 gene or protein." This invention relates to an ex vivo method of diagnosing or predicting HSP in a subject. The method involves detecting a mutation in the ZFYVE26 gene or protein, known as spastizin, which is indicative of hereditary spastic paraplegias.
Career Highlights
Throughout his career, Hanein has worked with prestigious institutions such as the Institut National de la Santé et de la Recherche Médicale and Inserm. His research has focused on genetic disorders, contributing to advancements in medical diagnostics and treatment options.
Collaborations
Hanein has collaborated with notable colleagues in his field, including Giovanni Stevanin and Amir Boukhris. These partnerships have enhanced the scope and impact of his research.
Conclusion
Sylvain Hanein's innovative work in genetic diagnosis exemplifies the importance of research in understanding hereditary conditions. His contributions continue to influence the field and improve diagnostic methods for hereditary spastic paraplegias.